scorecardresearch
Bharat Biotech

Bharat Biotech

 

More Stories on Bharat Biotech
Covaxin

‘Continuing to work diligently’: Bharat Biotech responds to WHO on Covaxin EUL

Sep 17, 2021

Bharat Biotech, popularly known for vaccine manufacturing, said it has provided the global health watchdog with all the details and is awaiting Emergency Use Listing approval.

Covaxin in one of the vaccines being administered in the country under the nationwide vaccination programme against coronavirus.

WHO to approve Bharat Biotech's COVID-19 vaccine Covaxin this week: Report

Sep 13, 2021

So far, the WHO has approved COVID-19 vaccines of Pfizer-BioNTech, AstraZeneca-SK Bio or Serum Institute of India, Johnson & Johnson, Moderna, and Sinopharm.

WHO panel to meet this week to review Covaxin

WHO approval for Covaxin likely in mid-Sept

Sep 01, 2021

WHO’s approval will also allow Bharat Biotech to export Covaxin and enable easy international travel for people who have received the vaccine

On Sunday, the company rolled out the first batch of COVAXIN shots from a facility in Ankleshwar in western India that has the capacity to produce more than 10 million doses per month

Bharat Biotech seeks international partners to manufacture COVID-19 vaccine

Aug 30, 2021

COVAXIN, the company's home-grown COVID-19 vaccine approved for emergency use in India, is one of two shots driving the country's massive vaccination programme

The development is significant since the country is trying to augment Covid-19 vaccine production capacity to meet its vaccination target

IIL starts raw material supply to Bharat Biotech for augmenting Covaxin production

Aug 13, 2021

The Central government had directed IIL and Bharat Biotech to join hands in April, as Bharat Biotech was struggling to augment its capacity. IIL also received a grant of Rs 60 crore towards enhancing production capabilities

BBV154 is an intranasal replication-deficient chimpanzee adenovirus SARS-CoV-2 vectored vaccine

Bharat Biotech gets regulator's nod to conduct phase 2/3 trial of its nasal COVID-19 vaccine

Aug 13, 2021

Bharat Biotech has developed the nasal COVID-19 vaccine candidate with support from the department of biotechnology (DBT) and its PSU, Biotechnology Industry Research Assistance Council (BIRAC)

Covaxin is still to be authorised by Western authorities

WHO decision on COVAXIN approval in Sept

Aug 12, 2021

A top vaccines official at the World Health Organization says the agency expects to make a decision next month on an emergency authorization for the Indian-made Covid-19 vaccine made by Bharat Biotech

The study, including the clinical trials, will be held by the Christian Medical College, Vellore.

DCGI nod to study on mixing of Covishield, Covaxin: Sources

Aug 10, 2021

On July 29, Central Drugs Standard Control Organisation's Subject Expert Committee had recommended a study on mixing of both Covid-19 vaccines

In May, Bharat Biotech had announced that it will ramp up production of Covaxin by manufacturing additional 200 million doses at Ankleshwar facility.

Govt approves Ankleshwar manufacturing facility for production of Covaxin

Aug 10, 2021

The approval to this facility will increase vaccine availability and accelerate India's vaccination programme against COVID-19, Mandaviya said.

Facility augmentation is being implemented by the Biotechnology Industry Research Assistance Council (BIRAC), a PSU of DBT

Centre supporting facility augmentation of Bharat Biotech, 3 PSEs: Mandaviya

Aug 06, 2021

The minister stated that this facility augmentation is being done under the “Mission COVID Suraksha- the Indian COVID-19 Vaccine Development Mission”

India currently gets about 2 crore doses of Covaxin and 10 crore doses of Covishield from the Serum Institute of India. Covaxin supplies were projected to increase to around 2.5 crore doses in August

'Fake news and false narrative': Bharat Biotech on concerns over Covaxin efficacy, low production

Aug 05, 2021

Indirectly referring to reports that some early batches made in Bengaluru were of poor quality, Bharat Biotech said to date, all its batches were manufactured and released only from its facilities at Genome Valley, Hyderabad